Nyumbani › Magonjwa ya Mapafu ya Interstitial
Majaribio ya kliniki ya Magonjwa ya Mapafu ya Interstitial yanayovutia washiriki nchini Marekani
Masomo 53 ya Magonjwa ya Mapafu ya Interstitial yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- New York City, NYUtafiti 18
- Philadelphia, PAUtafiti 16
- Los Angeles, CAUtafiti 14
- Durham, NCUtafiti 13
- Kansas City, KSUtafiti 13
- Charleston, SCUtafiti 13
- Chicago, ILUtafiti 12
- Houston, TXUtafiti 12
- Ann Arbor, MIUtafiti 11
- Aurora, COUtafiti 11
- Salt Lake City, UTUtafiti 9
- Phoenix, AZUtafiti 9
- Boston, MAUtafiti 9
- Rochester, MNUtafiti 9
- Birmingham, ALUtafiti 9
- Orlando, FLUtafiti 9
- Dallas, TXUtafiti 9
- Cincinnati, OHUtafiti 8
- Tampa, FLUtafiti 8
- Minneapolis, MNUtafiti 8
- Bend, ORUtafiti 7
- San Francisco, CAUtafiti 7
- Richmond, VAUtafiti 6
- Washington, DCUtafiti 6
- Denver, COUtafiti 6
- Indianapolis, INUtafiti 6
- Gainesville, FLUtafiti 5
- Naples, FLUtafiti 5
- Columbus, OHUtafiti 5
- Jacksonville, FLUtafiti 5
- Winston-Salem, NCUtafiti 5
- Oklahoma City, OKUtafiti 5
- Cleveland, OHUtafiti 5
- Albuquerque, NMUtafiti 5
- Nashville, TNUtafiti 5
- Pittsburgh, PAUtafiti 5
- Scottsdale, AZUtafiti 4
- New Haven, CTUtafiti 4
- Rochester, NYUtafiti 4
- St. Louis, MOUtafiti 4
Kwa jimbo
- AlabamaUtafiti 9
- ArizonaUtafiti 13
- CaliforniaUtafiti 22
- ColoradoUtafiti 15
- ConnecticutUtafiti 4
- FloridaUtafiti 24
- GeorgiaUtafiti 3
- IllinoisUtafiti 12
- IndianaUtafiti 6
- KansasUtafiti 13
- KentuckyUtafiti 4
- LouisianaUtafiti 5
- MarylandUtafiti 5
- MassachusettsUtafiti 11
- MichiganUtafiti 16
- MinnesotaUtafiti 14
- MississippiUtafiti 3
- MissouriUtafiti 6
- NevadaUtafiti 4
- New JerseyUtafiti 3
- New MexicoUtafiti 5
- New YorkUtafiti 20
- North CarolinaUtafiti 18
- OhioUtafiti 14
- OklahomaUtafiti 5
- OregonUtafiti 9
- PennsylvaniaUtafiti 18
- South CarolinaUtafiti 14
- TennesseeUtafiti 7
- TexasUtafiti 18
- UtahUtafiti 9
- VirginiaUtafiti 8
- Wilaya ya ColumbiaUtafiti 5
- WisconsinUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
InaajiriHatua 3
Umri 40 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT05798923Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
InaajiriHatua 3
Umri 18 hadi 100 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07613099Pulmonary Fibrosis Foundation Community Registry
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT05382572A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07323732A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
InaajiriHatua 3
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07816185SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07269262A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06572384Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
InaajiriHatua 2/3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
InaajiriHatua 2
Umri 40 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
InaajiriHatua 3
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
InaajiriHatua 2
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT07333183Dorothy P. and Richard P. Simmons Center for ILD Research Registry
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT07486869PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT06855329Platform Clinical Study for Conquering Scleroderma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
InaajiriHatua 2/3
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06328777Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
InaajiriHatua 2
Umri 8 hadi 60 · Jinsia zote · Imesasishwa 14 Ago 2026 · NCT03630211An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Ago 2026 · NCT07234032Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.